These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29096893)

  • 1. Therapeutic Use of Estrogen Receptor β Agonists in Prevention and Treatment of Endocrine Therapy Resistant Breast Cancers: Observations From Preclinical Models.
    Ramasamy K; Samayoa C; Krishnegowda N; Tekmal RR
    Prog Mol Biol Transl Sci; 2017; 151():177-194. PubMed ID: 29096893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptors in breast carcinogenesis and endocrine therapy.
    Huang B; Warner M; Gustafsson JÅ
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():240-4. PubMed ID: 25433206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.
    Liu J; Viswanadhapalli S; Garcia L; Zhou M; Nair BC; Kost E; Rao Tekmal R; Li R; Rao MK; Curiel T; Vadlamudi RK; Sareddy GR
    Oncotarget; 2017 Jul; 8(30):50002-50014. PubMed ID: 28654894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines.
    Lattrich C; Schüler S; Häring J; Skrzypczak M; Ortmann O; Treeck O
    Arch Gynecol Obstet; 2014 Jan; 289(1):163-71. PubMed ID: 23907354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy.
    Ruddy SC; Lau R; Cabrita MA; McGregor C; McKay BC; Murphy LC; Wright JS; Durst T; Pratt MA
    Mol Cancer Ther; 2014 Jul; 13(7):1882-93. PubMed ID: 24785256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of estrogen receptor-β in breast cancer.
    Murphy LC; Leygue E
    Semin Reprod Med; 2012 Jan; 30(1):5-13. PubMed ID: 22271289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen Receptor Beta Selective Agonists as Agents to Treat Chemotherapeutic-Induced Neuropathic Pain.
    Ma JN; McFarland K; Olsson R; Burstein ES
    ACS Chem Neurosci; 2016 Sep; 7(9):1180-7. PubMed ID: 27456785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
    Skliris GP; Leygue E; Watson PH; Murphy LC
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):1-10. PubMed ID: 18243688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor-β activation in combination with letrozole blocks the growth of breast cancer tumors resistant to letrozole therapy.
    Nair HB; Kirma NB; Ganapathy M; Vadlamudi RK; Tekmal RR
    Steroids; 2011 Jul; 76(8):792-6. PubMed ID: 21477609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
    Chang EC; Frasor J; Komm B; Katzenellenbogen BS
    Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
    Borgquist S; Holm C; Stendahl M; Anagnostaki L; Landberg G; Jirström K
    J Clin Pathol; 2008 Feb; 61(2):197-203. PubMed ID: 18223096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor beta in breast cancer.
    Haldosén LA; Zhao C; Dahlman-Wright K
    Mol Cell Endocrinol; 2014 Jan; 382(1):665-672. PubMed ID: 23954741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen Receptor β as a Possible Double-Edged Sword Molecule in Breast Cancer: A Mechanism of Alteration of Its Role by Exposure to Endocrine-Disrupting Chemicals.
    Hirao-Suzuki M
    Biol Pharm Bull; 2021; 44(11):1594-1597. PubMed ID: 34719637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
    Felzen V; Hiebel C; Koziollek-Drechsler I; Reißig S; Wolfrum U; Kögel D; Brandts C; Behl C; Morawe T
    Cell Death Dis; 2015 Jul; 6(7):e1812. PubMed ID: 26158518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patients.
    Altundag O; Altundag K; Gunduz M
    Med Hypotheses; 2004; 63(4):684-7. PubMed ID: 15325017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells.
    Dago DN; Scafoglio C; Rinaldi A; Memoli D; Giurato G; Nassa G; Ravo M; Rizzo F; Tarallo R; Weisz A
    BMC Genomics; 2015 May; 16(1):367. PubMed ID: 25956916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer.
    Iwase H; Zhang Z; Omoto Y; Sugiura H; Yamashita H; Toyama T; Iwata H; Kobayashi S
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S34-8. PubMed ID: 12819932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.